TP53 mutation is the most common, accounting for 66% of all mutation types in HNSCC and up to 75% in non-HPV-related HNSCC (Zhou et al., 2016; Klinakis and Rampias, 2020). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.